Non-Carrier Nanoparticles Adjuvant Modular Protein Vaccine in a Particle-Dependent Manner

Nanoparticles are increasingly used to adjuvant vaccine formulations due to their biocompatibility, ease of manufacture and the opportunity to tailor their size, shape, and physicochemical properties. The efficacy of similarly-sized silica (Si-OH), poly (D,L-lactic-co-glycolic acid) (PLGA) and poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Seth, Arjun, Ritchie, Fiona K., Wibowo, Nani, Lua, Linda H. L., Middelberg, Anton P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355484/
https://www.ncbi.nlm.nih.gov/pubmed/25756283
http://dx.doi.org/10.1371/journal.pone.0117203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355484/
https://www.ncbi.nlm.nih.gov/pubmed/25756283
http://dx.doi.org/10.1371/journal.pone.0117203

Ejemplares similares